Efficacy and Safety Evaluation of Budesonide/Formoterol SPIROMAX® Inhalation Powder Versus SYMBICORT® TURBOHALER®
Clinical trial NCT01803555 · COMPLETED
Trial details
- NCT number
- NCT01803555
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-07-04
- Primary completion
- 2014-03-20
- Enrollment
- 605
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.